France, US Discuss Drug Pricing Trade Probe

The United States is engaging in discussions with France and other countries to avoid trade investigations into pharmaceutical pricing practices. The U.S. launched an investigation into Germany’s drug pricing policies under Section 301 of the Trade Act of 1974, threatening similar actions against other nations. This situation is driven by the U.S. administration’s desire to increase spending on U.S. drugs and secure commitments from trading partners.

Summarized from the sources above. Read the originals for the full story.